This invention relates to the field of
biomedical technology, specifically disclosing a biomimetic
bacterial DNA nanomicelle, its preparation method, and its applications. By mimicking the structural and functional characteristics formed when microorganisms infect a host, exogenous
nucleic acid stimulation signals and
oxidative stress regulation functions are integrated into a single
nanostructure. A micellar
nanostructure is designed, comprising a complex of oligonucleotides containing CpG motifs and
ferrocene groups, which is formed through self-
assembly in solution. This nanomicelle can significantly promote the proliferation or differentiation of dendritic cells, improve their maturity, and enhance their
immune activation capacity; by enhancing the cross-presentation capacity of dendritic cells to target antigens, it effectively promotes cytotoxic CD8+. + T-
cell immune responses; it can also enhance the body's cellular immune response by inducing the activation and proliferation of
antigen-specific cells. These
DNA nanomicelles have significant clinical application value in areas such as vaccine adjuvants, tumor
immunotherapy, and
immune regulation.